SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-236586
Filing Date
2012-05-16
Accepted
2012-05-16 16:11:07
Documents
3
Period of Report
2012-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d354037d8k.htm 8-K 43307
2 EQUITY INCENTIVE PLAN. d354037dex991.htm EX-99.1 72916
3 EMPLOYEE STOCK PURCHASE PLAN. d354037dex992.htm EX-99.2 51030
  Complete submission text file 0001193125-12-236586.txt   168563
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 12848926
SIC: 2834 Pharmaceutical Preparations